Of depression and immunity: Does sex matter?

International Journal of Neuropsychopharmacology

Volumn 13, Issue 5, 2010, Pages 675-689

  Pitychoutis, Pothitos M ^a   Papadopoulou Daifoti, Zeta ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Cytokines; Immune system; Lymphocytes; Stress; Women

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; ETANERCEPT; FLUOXETINE; REBOXETINE; SEX HORMONE;

CLINICAL TRIAL; CYTOKINE RELEASE; DEPRESSION; DISEASE ASSOCIATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; INFLAMMATION; INNATE IMMUNITY; MAJOR DEPRESSION; MORTALITY; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SEX DIFFERENCE; STRESS;

ANIMALS; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; IMMUNITY; MALE; NEURAL PATHWAYS; NEUROIMMUNOMODULATION; SEX CHARACTERISTICS;

EID: 77953488959     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710000465     Document Type: Review

References (177)

1. Adam TC, Epel ES (2007). Stress, eating and the reward system. Physiology and Behavior 91, 449-458.
2. Ahmed SA, Talal N (1990). Sex hormones and the immune system-Part 2. Animal data. Baillieres Clinical Rheumatology 4, 13-31.
3. Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, et al. (2009). Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depression and Anxiety 26, 607-611.
4. Angele MK, Schwacha MG, Ayala A, Chaudry IH (2000). Effect of gender and sex hormones on immune responses following shock. Shock 14, 81-90.
5. Ansar Ahmed S, Penhale WJ, Talal N (1985). Sex hormones, immune responses, and autoimmune diseases. mechanisms of sex hormone action. American Journal of Pathology 121, 531-551.
6. Antonijevic IA (2006). Depressive disorders-is it time to endorse different pathophysiologies? Psychoneuroendocrinology 31, 1-15.
7. APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text Revision. Washington DC: American Psychiatric Association.
8. Arevalo MA, Santos-Galindo M, Bellini MJ, Azcoitia I, et al. (2009). Actions of estrogens on glial cells: implications for neuroprotection. Biochimica et Biophysica Acta. Published online: 8 October 2009. doi:10.1016/j.bbagen.2009.10.002.
9. Avitsur R, Cohen E, Yirmiya R (1997). Effects of interleukin-1 on sexual attractivity in a model of sickness behavior. Physiology and Behavior 63, 25-30.
10. Avitsur R, Donchin O, Barak O, Cohen E, et al. (1995). Behavioral effects of interleukin-1 beta: modulation by gender, estrus cycle, and progesterone. Brain, Behavior, and Immunity 9, 234-241.
11. Avitsur R, Yirmiya R (1999). The immunobiology of sexual behavior: gender differences in the suppression of sexual activity during illness. Pharmacology, Biochemistry and Behavior 64, 787-796.
12. Azpiroz A, Fano E, Garmendia L, Arregi A, et al. (1999). Effects of chronic mild stress (CMS) and imipramine administration, on spleen mononuclear cell proliferative response, serum corticosterone level and brain norepinephrine content in male mice. Psychoneuroendocrinology 24, 345-361.
13. Bastard JP, Maachi M, Lagathu C, Kim MJ, et al. (2006). Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network 17, 4-12.
14. Bekris S, Antoniou K, Daskas S, Papadopoulou-Daifoti Z (2005). Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behavioral Brain Research 161, 45-59.
15. Bismar H, Diel I, Ziegler R, Pfeilschifter J (1995). Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. Journal of Clinical Endocrinology and Metabolism 80, 3351-3355.
16. Bonaccorso S, Marino V, Biondi M, Grimaldi F, et al. (2002). Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. Journal of Affective Disorders 72, 237-241.
17. Bouman A, Schipper M, Heineman MJ, Faas MM (2004). Gender difference in the non-specific and specific immune response in humans. American Journal of Reproductive Immunology 52, 19-26.
18. Breslau N, Schultz L, Peterson E (1995). Sex differences in depression: a role for preexisting anxiety. Psychiatry Research 58, 1-12.
19. Brown KJ, Grunberg NE (1995). Effects of housing on male and female rats: crowding stresses males but calms females. Physiology and Behavior 58, 1085-1089.
20. Cannon JG (1998). Adaptive interactions between cytokines and the hypothalamic-pituitary-gonadal axis. Annals of the New York Academy of Sciences 856, 234-242.
21. Capuron L, Gumnick JF, Musselman DL, Lawson DH, et al. (2002). Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26, 643-652.
22. Capuron L, Miller AH (2004). Cytokines and psychopathology: lessons from interferon-alpha. Biological Psychiatry 56, 819-824.
23. Capuron L, Miller A, Irwin M (2006). Psychoneuroimmunology of depressive disorder: mechanisms and clinical implications. In: Ader R (Ed.), Psychoneuroimmunology, 4th edn (pp. 281-318).
24. San Diego: Academic Press. Chen JR, Yan YT, Wang TJ, Chen LJ, Wang YJ, Tseng GF (2009). Gonadal hormones modulate the dendritic spine densities of primary cortical pyramidal neurons in adult female rat. Cerebral Cortex 19, 2719-2727.
25. Clerici M, Arosio B, Mundo E, Cattaneo E, et al. (2009). Cytokine polymorphisms in the pathophysiology of mood disorders. CNS Spectrum 14, 419-425
26. Cooke BM, Woolley CS (2005). Gonadal hormone modulation of dendrites in the mammalian cNS. Journal of Neurobiology 64, 34-46.
27. Cosgrove KP, Mazure CM, Staley JK (2007). Evolving knowledge of sex differences in brain structure, function, and chemistry. Biological Psychiatry 62, 847-855.
28. Cuijpers P, Smit F (2002). Excess mortality in depression: a meta-analysis of community studies. Journal of Affective Disorders 72, 227-236.
29. Dalla C, Antoniou K, Drossopoulou G, Xagoraris M, et al. (2005). Chronic mild stress impact: are females more vulnerable? Neuroscience 135, 703-714.
30. Dalla C, Antoniou K, Kokras N, Drossopoulou G, et al. (2008a). Sex differences in the effects of two stress paradigms on dopaminergic neurotransmission. Physiology and Behavior 93, 595-605.
31. Dalla C, Edgecomb C, Whetstone AS, Shors TJ (2008b). Females do not express learned helplessness like males do. Neuropsychopharmacology 33, 1559-1569.
32. Dalla C, Pitychoutis PM, Kokras N, Papadopoulou-Daifoti Z (2010). Sex differences in animal models of depression and antidepressant response. Basic & Clinical Pharmacology & Toxicology 106, 226-233.
33. Dalla C, Whetstone AS, Hodes GE, Shors TJ (2009). Stressful experience has opposite effects on dendritic spines in the hippocampus of cycling vs. masculinized females. Neuroscience Letters 449, 52-56.
34. Dantzer R (2001). Cytokine-induced sickness behavior: mechanisms and implications. Annals of the New York Academy of Sciences 933, 222-234.
35. Dantzer R, O'Connor JC, Freund GG, Johnson RW, et al. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 9, 46-56.
36. Darnall B, Zwickey H, Aickin M (2008). Interleukin-6 response to in-vivo pain catastrophizing: comparison by gender. Journal of Women's Health 17, 1248.
37. Darnall BD, Suarez EC (2009). Sex and gender in psychoneuroimmunology research: past, present and future. Brain, Behavior, and Immunity 23, 595-604.
38. De Leon-Nava MA, Nava K, Soldevila G, Lopez-Griego L, et al. (2009). Immune sexual dimorphism: effect of gonadal steroids on the expression of cytokines, sex steroid receptors, and lymphocyte proliferation. Journal of Steroid Biochemistry and Molecular Biology 113, 57-64.
39. Dimayuga FO, Reed JL, Carnero GA, Wang C, et al. (2005). Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines. Journal of Neuroimmunology 161, 123-136.
40. Drossopoulou G, Antoniou K, Kitraki E, Papathanasiou G, et al. (2004). Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience 126, 849-857.
41. Edgar VA, Cremaschi GA, Sterin-Borda L, Genaro AM (2002). Altered expression of autonomic neurotransmitter receptors and proliferative responses in lymphocytes from a chronic mild stress model of depression: effects of fluoxetine. Brain, Behavior, and Immunity 16, 333-350.
42. Edgar VA, Silberman DM, Cremaschi GA, Zieher LM, et al. (2003). Altered lymphocyte catecholamine reactivity in mice subjected to chronic mild stress. Biochemical Pharmacology 65, 15-23.
43. Edwards KM, Burns VE, Reynolds T, Carroll D, et al. (2006). Acute stress exposure prior to influenza vaccination enhances antibody response in women. Brain, Behavior, and Immunity 20, 159-168.
44. Eisenberger NI, Inagaki TK, Rameson LT, Mashal NM, et al. (2009). An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage 47, 881-890.
45. Elenkov IJ (2008). Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochemistry International 52, 40-51.
46. Engeland CG, Kavaliers M, Ossenkopp KP (2003). Sex differences in the effects of muramyl dipeptide and lipopolysaccharide on locomotor activity and the development of behavioral tolerance in rats. Pharmacology, Biochemistry, and Behavior 74, 433-447.
47. Engeland CG, Kavaliers M, Ossenkopp KP (2006). Influence of the estrous cycle on tolerance development to LPS-induced sickness behaviors in rats. Psychoneuroendocrinology 31, 510-525.
48. Estrada-Camarena E, Fernandez-Guasti A, Lopez-Rubalcava C (2006a). Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test. Neuropsychopharmacology 31, 247-255.
49. Estrada-Camarena E, Lopez-Rubalcava C, Fernandez-Guasti A (2006b). Facilitating antidepressant-like actions of estrogens are mediated by 5-HT1A and estrogen receptors in the rat forced swimming test. Psychoneuroendocrinology 31, 905-914.
50. Evans DL, Folds JD, Petitto JM, Golden RN, et al. (1992). Circulating natural killer cell phenotypes in men and women with major depression. relation to cytotoxic activity and severity of depression. Archives of General Psychiatry 49, 388-395.
51. Evans DL, Ten Have TR, Douglas SD, Gettes DR, et al. (2002). Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with hIV infection. American Journal of Psychiatry 159, 1752-1759.
52. Fish EN (2008). The X-files in immunity: sex-based differences predispose immune responses. Nature Reviews Immunology 8, 737-744.
53. Folstad I, Karter J (1992). Parasites, bright males, and the immunocompetence handicap. American Naturalist 139, 603-622.
54. Fontana RJ, Schwartz SM, Gebremariam A, Lok AS, et al. (2002). Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C. Psychosomatics 43, 378-385.
55. Fox HS, Bond BL, Parslow TG (1991). Estrogen regulates the iFN-gamma promoter. Journal of Immunology 146, 4362-4367.
56. Frederic F, Oliver C, Wollman E, Delhaye-Bouchaud N, et al. (1993). IL-1 and lPS induce a sexually dimorphic response of the hypothalamo-pituitary- adrenal axis in several mouse strains. European Cytokine Network 4, 321-329.
57. Gaillard RC, Spinedi E (1998). Sex-and stress-steroids interactions and the immune system: evidence for a neuroendocrine-immunological sexual dimorphism. Domestic Animal Endocrinology 15, 345-352.
58. Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, et al. (2000). In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. Journal of Clinical Endocrinology and Metabolism 85, 1648-1657.
59. Gohier B, Goeb JL, Rannou-Dubas K, Fouchard I, et al. (2003). Hepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patients. World Journal of Biological Psychiatry 4, 115-118.
60. Goldstein JM, Jerram M, Abbs B, Whitfield-Gabrieli S, et al. (2010). Sex differences in stress response circuitry activation dependent on female hormonal cycle. Journal of Neuroscience 30, 431-438.
61. Gonsky R, Deem RL, Bream JH, Young HA, et al. (2006). An IFNG SNP with an estrogen-like response element selectively enhances promoter expression in peripheral but not lamina propria T cells. Genes & Immunity 7, 342-351.
62. Grant BF, Hasin DS, Chou SP, Stinson FS, et al. (2004). Nicotine dependence and psychiatric disorders in the United States. Archives of General Psychiatry 61, 1107-1115.
63. Grewal IS, Heilig M, Miller A, Sercarz EE (1997). Environmental regulation of T-cell function in mice: group housing of males affects accessory cell function. Immunology 90, 165-168.
64. Grigoriadis S, Robinson GE (2007). Gender issues in depression. Annals of Clinical Psychiatry 19, 247-255.
65. Grossman CJ (1984). Regulation of the immune system by sex steroids. Endocrine Reviews 5, 435-455.
66. Grossman CJ, Roselle GA, Mendenhall CL (1991). Sex steroid regulation of autoimmunity. Journal of Steroid Biochemistry and Molecular Biology 40, 649-659.
67. Halbreich U, Kahn LS (2001). Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs 15, 797-817.
68. Haller J, Fuchs E, Halasz J, Makara GB (1999). Defeat is a major stressor in males while social instability is stressful mainly in females: towards the development of a social stress model in female rats. Brain Research Bulletin 50, 33-39.
69. Harmey JH, Bucana CD, Lu W, Byrne AM, et al. (2002). Lipopolysaccharide- induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. International Journal of Cancer 101, 415-422.
70. Hasler G, Drevets WC, Manji HK, Charney DS (2004). Discovering endophenotypes for major depression. Neuropsychopharmacology 2, 1765-1781.
71. Herbert TB, Cohen S (1993). Depression and immunity: a meta-analytic review. Psychology Bulletin 113, 472-486.
72. Heyward VH, Stolarczyk LM (1996). Body composition and levels of body fatness. In: Heyward VH, Stolarczyk LM (Eds), Applied Body Composition Assessment (pp. 135-142).
73. Champaign, IL: Human Kinetics Publishers. Holden C (2005). Sex and the suffering brain. Science 308, 1574.
74. Howren MB, Lamkin DM, Suls J (2009). Associations of depression with c-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine 71, 171-186.
75. Husky MM, Mazure CM, Paliwal P, McKee SA (2008). Gender differences in the comorbidity of smoking behavior and major depression. Drug and Alcohol Dependence 93, 176-179.
76. Irwin M (1999). Immune correlates of depression. Advances in Experimental Medicine and Biology 461, 1-24.
77. Irwin M, Costlow C, Williams H, Artin KH, et al. (1998). Cellular immunity to varicella-zoster virus in patients with major depression. Journal of Infectious Diseases 178 (Suppl. 1), S104-108.
78. Irwin MR, Wang M, Ribeiro D, Cho HJ, et al. (2008). Sleep loss activates cellular inflammatory signaling. Biological Psychiatry 64, 538-540.
79. Iwasaki-Sekino A, Mano-Otagiri A, Ohata H, Yamauchi N, et al. (2009). Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology 34, 226-237.
80. Jansson M, Gatz M, Berg S, Johansson B, et al. (2004). Gender differences in heritability of depressive symptoms in the elderly. Psychological Medicine 34, 471-479.
81. Kamper EF, Chatzigeorgiou A, Tsimpoukidi O, Kamper M, et al. (2009). Sex differences in oxidant/antioxidant balance under a chronic mild stress regime. Physiology and Behavior 98, 215-222.
82. Kendler KS, Gatz M, Gardner CO, Pedersen NL (2006). A swedish national twin study of lifetime major depression. American Journal of Psychiatry 163, 109-114.
83. Kessler RC (2003). Epidemiology of women and depression. Journal of Affective Disorders 74, 5-13.
84. Kessler RC, Berglund P, Demler O, Jin R, et al. (2003). The epidemiology of major depressive disorder: results from the national comorbidity survey replication (NCS-R). Journal of the American Medical Association 289, 3095-3105.
85. Kessler RC, Sonnega A, Bromet E, Hughes M, et al. (1995). Posttraumatic stress disorder in the national comorbidity survey. Archives of General Psychiatry 52, 1048-1060.
86. Khairova RA, Machado-Vieira R, Du J, Manji HK (2009). A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. International Journal of Neuropsychopharmacology 12, 561-578.
87. Kim Y-K, Na K-S, Shin K-H, Jung H-Y, et al. (2007). Cytokine imbalance in the pathophysiology of major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31, 1044-1053.
88. Kioukia-Fougia N, Antoniou K, Bekris S, Liapi C, et al. (2002). The effects of stress exposure on the hypothalamic-pituitary-adrenal axis, thymus, thyroid hormones and glucose levels. Progress in Neuropsychopharmacology and Biological Psychiatry 26, 823-830.
89. Kornstein SG (1997). Gender differences in depression: implications for treatment. Journal of Clinical Psychiatry 58 (Suppl. 15), 12-18.
90. Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, et al. (2000). Gender differences in treatment response to sertraline vs. imipramine in chronic depression. American Journal of Psychiatry 157, 1445-1452.
91. Koskinas J, Merkouraki P, Manesis E, Hadziyannis S (2002). Assessment of depression in patients with chronic hepatitis: effect of interferon treatment. Digestive Diseases 20, 284-288.
92. Kraus MR, Schafer A, Faller H, Csef H, et al. (2003). Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. Journal of Clinical Psychiatry 64, 708-714.
93. Krzych U, Strausser HR, Bressler JP, Goldstein AL (1981). Effects of sex hormones on some t and b cell functions, evidenced by differential immune expression between male and female mice and cyclic pattern of immune responsiveness during the estrous cycle in female mice. American Journal of Reproductive Immunology 1, 73-77.
94. Kubera M, Basta-Kaim A, Holan V, Simbirtsev A, et al. (1998). Effect of mild chronic stress, as a model of depression, on the immunoreactivity of C57BL/6 mice. International Journal of Immunopharmacology 20, 781-789.
95. Kubera M, Maes M, Holan V, Basta-Kaim A, et al. (2001). Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. Journal of Affective Disorders 63, 171-178.
96. Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22, 370-379.
97. Laroux FS (2004). Mechanisms of inflammation: the good, the bad and the ugly. Frontiers in Bioscience 9, 3156-3162.
98. Lengi AJ, Phillips RA, Karpuzoglu E, Ahmed SA (2007). Estrogen selectively regulates chemokines in murine splenocytes. Journal of Leukocyte Biology 81, 1065-1074.
99. Leposavic G, Pilipovic I, Radojevic K, Pesic V, et al. (2008). Catecholamines as immunomodulators: a role for adrenoceptor-mediated mechanisms in fine tuning of T-cell development. Autonomic Neuroscience 144, 1-12.
100. Leserman J (2003). HIV disease progression: depression, stress, and possible mechanisms. Biological Psychiatry 54, 295-306. (Pubitemid 37267859)
101. Leserman J (2008). Role of depression, stress, and trauma in HIV disease progression. Psychosomatic Medicine 70, 539-545.
102. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, et al. (2010). Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Archives of General Psychiatry 67, 220-229.
103. Maes M (1994). Cytokines in major depression. Biological Psychiatry 36, 498-499.
104. Marcus SM, Kerber KB, Rush AJ, Wisniewski SR, et al. (2008). Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the sequenced treatment alternatives to relieve depression study. Comprehensive Psychiatry 49, 238-246.
105. Marcus SM, Young EA, Kerber KB, Kornstein S, et al. (2005). Gender differences in depression: findings from the STAR*D study. Journal of Affective Disorders 87, 141-150.
106. Marriott I, Bost KL, Huet-Hudson YM (2006). Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibility. Journal of Reproductive Immunology 71, 12-27.
107. McCombe PA, Greer JM, Mackay IR (2009). Sexual dimorphism in autoimmune disease. Current Molecular Medicine 9, 1058-1079.
108. McCoy SJ, Beal JM, Saunders B, Hill EN, et al. (2008). Risk factors for postpartum depression: a retrospective investigation. Journal of Reproductive Medicine 53, 166-170.
109. McNally L, Bhagwagar Z, Hannestad J (2008). Inflammation, glutamate, and glia in depression: a literature review. CNS Spectrum 13, 501-510.
110. Mendlewicz J, Kriwin P, Oswald P, Souery D, et al. (2006). Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. International Clinical Psychopharmacology 21, 227-231.
111. Merali Z, Brennan K, Brau P, Anisman H (2003). Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for 'free chow' and 'earned' sucrose intake. Psychopharmacology (Berlin) 165, 413-418.
112. Mesquita AR, Correia-Neves M, Roque S, Castro AG, et al. (2008). IL-10 modulates depressive-like behavior. Journal of Psychiatric Research 43, 89-97.
113. Migeon BR (2007). Why females are mosaics, X-chromosome inactivation, and sex differences in disease. Gender Medicine 4, 97-105.
114. Miller AH (2010). Depression and immunity: a role for T cells? Brain, Behavior, and Immunity 24, 1-8.
115. Miller AH, Maletic V, Raison CL (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 65, 732-741.
116. Mohamed-Ali V, Pinkney JH, Coppack SW (1998). Adipose tissue as an endocrine and paracrine organ. International Journal of Obesity and Related Metabolic Disorders 22, 1145-1158.
117. MohanKumar SM, MohanKumar PS, Quadri SK (1999). Lipopolysaccharide- induced changes in monoamines in specific areas of the brain: blockade by interleukin-1 receptor antagonist. Brain Research 824, 232-237.
118. Morale MC, Gallo F, Tirolo C, Testa N, et al. (2001). Neuroendocrine-immune (NEI) circuitry from neuron-glial interactions to function: focus on gender and HPA-HPG interactions on early programming of the NEI system. Immunology & Cell Biology 79, 400-417.
119. Mossner R, Mikova O, Koutsilieri E, Saoud M, et al. (2007). Consensus paper of the wFSBP task force on biological markers: biological markers in depression. World Journal of Biological Psychiatry 8, 141-174.
120. Muller N, Schwarz MJ, Dehning S, Douhe A, et al. (2006). The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Molecular Psychiatry 11, 680-684.
121. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, et al. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New England Journal of Medicine 344, 961-966.
122. Myint AM, Leonard BE, Steinbusch HW, Kim YK (2005). Th1, Th2, and Th3 cytokine alterations in major depression. Journal of Affective Disorders 88, 167-173.
123. Nalbandian G, Kovats S (2005). Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunology Research 31, 91-106.
124. Naor R, Domankevich V, Shemer S, Sominsky L, et al. (2009). Metastatic-promoting effects of lPS: sexual dimorphism and mediation by catecholamines and prostaglandins. Brain, Behavior, and Immunity 23, 611-621.
125. Nemeroff CB, Bremner JD, Foa EB, Mayberg HS, et al. (2006). Posttraumatic stress disorder: a state-of-the-science review. Journal of Psychiatric Research 40, 1-21.
126. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, et al. (2002). Neurobiology of depression. Neuron 34, 13-25.
127. Nunn CL, Lindenfors P, Pursall ER, Rolff J (2009). On sexual dimorphism in immune function. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences 364, 61-69.
128. Olsen NJ, Kovacs WJ (1996). Gonadal steroids and immunity. Endocrine Reviews 17, 369-384.
129. Oxman MN, Levin MJ, Johnson GR, Schmader KE, et al. (2005). A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New England Journal of Medicine 352, 2271-2284.
130. Palanza P (2001). Animal models of anxiety and depression: how are females different? Neuroscience & Biobehavioral Reviews 25, 219-233.
131. Penninx BW, Geerlings SW, Deeg DJ, van Eijk JT, et al. (1999). Minor and major depression and the risk of death in older persons. Archives of General Psychiatry 56, 889-895.
132. Pernis AB (2007). Estrogen and CD4+ T cells. Current Opinion in Rheumatology 19, 414-420.
133. Pilipovic I, Vidic-Dankovic B, Perisic M, Radojevic K, et al. (2008). Sexual dimorphism in the catecholamine-containing thymus microenvironment: a role for gonadal hormones. Journal of Neuroimmunology 195, 7-20.
134. Pitychoutis PM, Griva E, Ioannou K, Tsitsilonis OE, et al. (2009a). Chronic antidepressant treatment exerts sexually dimorphic immunomodulatory effects in an experimental model of major depression: do females lack an advantage? International Journal of Neuropsychopharmacology 12, 1157-1163.
135. Pitychoutis PM, Nakamura K, Tsonis PA, Papadopoulou-Daifoti Z (2009b). Neurochemical and behavioral alterations in an inflammatory model of depression: sex differences exposed. Neuroscience 159, 1216-1232.
136. Prange-Kiel J, Fester L, Zhou L, Jarry H, et al. (2009). Estrus cyclicity of spinogenesis: underlying mechanisms. Journal of Neural Transmission 116, 1417-1425.
137. Raison CL, Demetrashvili M, Capuron L, Miller AH (2005). Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 19, 105-123.
138. Roberts RE, Kaplan GA, Camacho TC (1990). Psychological distress and mortality: evidence from the Alameda County Study. Social Science & Medicine 31, 527-536.
139. Rohleder N, Schommer NC, Hellhammer DH, Engel R, et al. (2001). Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosomatic Medicine 63, 966-972.
140. Rudisch B, Nemeroff CB (2003). Epidemiology of comorbid coronary artery disease and depression. Biological Psychiatry 54, 227-240.
141. Rush AJ (2007). STAR*D: what have we learned? American Journal of Psychiatry 164, 201-204.
142. Saad AH, Shoukrey N (1988). Sexual dimorphism on the immune responses of the snake, psammophis sibilans. Immunobiology 177, 404-419.
143. Sephton SE, Dhabhar FS, Keuroghlian AS, Giese-Davis J, et al. (2009). Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer. Brain, Behavior, and Immunity 23, 1148-1155.
144. Sierra A, Gottfried-Blackmore A, Milner TA, McEwen BS, et al. (2008). Steroid hormone receptor expression and function in microglia. Glia 56, 659-674.
145. Silberman DM, Wald M, Genaro AM (2002). Effects of chronic mild stress on lymphocyte proliferative response. participation of serum thyroid hormones and corticosterone. International Immunopharmacology 2, 487-497.
146. Smith RS (1991). The macrophage theory of depression. Medical Hypotheses 35, 298-306.
147. Soares CN, Almeida OP, Joffe H, Cohen LS (2001). Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Archives of General Psychiatry 58, 529-534.
148. Solomon MB, Herman JP (2009). Sex differences in psychopathology: of gonads, adrenals and mental illness. Physiology and Behavior 97, 250-258.
149. Somers JM, Goldner EM, Waraich P, Hsu L (2006). Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Canadian Journal of Psychiatry 51, 100-113.
150. Spinedi E, Gaillard RC, Chisari A (2002). Sexual dimorphism of neuroendocrine-immune interactions. Frontiers of Hormone Research 29, 91-107.
151. Spinedi E, Salas M, Chisari A, Perone M, et al. (1994). Sex differences in the hypothalamo-pituitary-adrenal axis response to inflammatory and neuroendocrine stressors. evidence for a pituitary defect in the autoimmune disease-susceptible female Lewis rat. Neuroendocrinology 60, 609-617.
152. Stefanski V, Gruner S (2006). Gender difference in basal and stress levels of peripheral blood leukocytes in laboratory rats. Brain, Behavior, and Immunity 20, 369-377.
153. Stein MB, Jang KL, Taylor S, Vernon PA, et al. (2002). Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study. American Journal of Psychiatry 159, 1675-1681.
154. Steiner M, Allgulander C, Ravindran A, Kosar H, et al. (2005). Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder. Human Psychopharmacology 20, 3-13.
155. Stewart DE, Ashraf IJ, Munce SE (2006). Women's mental health: a silent cause of mortality and morbidity. International Journal of Gynecology & Obstetrics 94, 343-349.
156. Stommel M, Given BA, Given CW (2002). Depression and functional status as predictors of death among cancer patients. Cancer 94, 2719-2727.
157. Suarez EC (2008). Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for gender disparity. Brain, Behavior, and Immunity 22, 960-968.
158. Suarez EC, Krishnan KR (2006). The relation of free plasma tryptophan to anger, hostility, and aggression in a nonpatient sample of adult men and women. Annals of Behavioral Medicine 31, 254-260.
159. Sullivan DA, Hann LE (1989). Hormonal influence on the secretory immune system of the eye: endocrine impact on the lacrimal gland accumulation and secretion of IgA and IgG. Journal of Steroid Biochemistry 34, 253-262.
160. Szuster-Ciesielska A, Slotwinska M, Stachura A, Marmurowska-Michalowska H, et al. (2008). Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Progress in Neuropsychopharmacology and Biological Psychiatry 32, 686-694.
161. Tonelli LH, Holmes A, Postolache TT (2008). Intranasal immune challenge induces sex-dependent depressive-like behavior and cytokine expression in the brain. Neuropsychopharmacology 33, 1038-1048.
162. Tsigos C, Chrousos GP (2002). Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research 53, 865-871.
163. Tyring S, Gottlieb A, Papp K, Gordon K, et al. (2006). Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367, 29-35.
164. Uhl K, Parekh A, Kweder S (2007). Females in clinical studies: where are we going? Clinical Pharmacology & Therapeutics 81, 600-602.
165. Vigod SN, Stewart DE (2009). Emergent research in the cause of mental illness in women across the lifespan. Current Opinion in Psychiatry 22, 396-400.
166. Weissman MM, Pilowsky DJ, Wickramaratne PJ, Talati A, et al. (2006). Remissions in maternal depression and child psychopathology: a STAR*D-child report. Journal of the American Medical Association 295, 1389-1398.
167. WHO (2005). Gender and women's mental health (http://www.who.int/mental- health/prevention/genderwomen/en/). Accessed 18 March 2010.
168. WHO (2009). Women's health (http://www.who.int/mediacentre/factsheets/ fs334/en/index.html). Accessed 20 March 2010.
169. Willner P (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90-110.
170. Wise DD, Felker A, Stahl SM (2008). Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-Related events in psychopharmacology. CNS Spectrums 13, 647-662.
171. Woiciechowsky C, Schoning B, Lanksch WR, Volk HD, et al. (1999). Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. Journal of Molecular Medicine 77, 769-780.
172. Wright CE, Strike PC, Brydon L, Steptoe A (2005). Acute inflammation and negative mood: mediation by cytokine activation. Brain, Behavior, and Immunity 19, 345-350.
173. Yirmiya R (1996). Endotoxin produces a depressive-like episode in rats. Brain Research 711, 163-174.
174. Young MA, Scheftner WA, Fawcett J, Klerman GL (1990). Gender differences in the clinical features of unipolar major depressive disorder. Journal of Nervous and Mental Disease 178, 200-203.
175. Zampeli E, Pitychoutis PM, Papadopoulou-Daifoti Z, Tiligada E (2009). Systemic challenge with lipopolysaccharide increases histamine levels in the conjunctiva and cartilage, but not hypothalamus of sprague dawley rats. Inflammation Research 58 (Suppl. 1), 49-50.
176. Zheng D, Macera CA, Croft JB, Giles WH, et al. (1997). Major depression and all-cause mortality among white adults in the united states. Annals of Epidemiology 7, 213-218.
177. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, et al. (2001). The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain, Behavior, and Immunity 15, 199-226.